Green Pharmaceuticals recalls anti-snoring aid over possible microbial contamination

173
1
Green Pharmaceuticals recalls anti-snoring aid over possible microbial contamination

Green Pharmaceuticals has issued a recall for its SnoreStop NasoSpray due to possible microbial contamination.

SnoreStop NasoSpray is used as an anti-snoring aid that can temporarily stop or reduce symptoms of non-apneic snoring. According to the recall notice, anti-snoring aid may contain microbial contamination known as Providencia rettgeri.

Providencia rettgeri can be life-threatening in those who are immunocompromised, although it is rarely associated with illnesses in humans.

Providencia rettgeri can cause bacteremia sepsis, pneumonia, invasive fungal rhinosinusitis or disseminated fungal infection, according to the Federal Drug Administration.

The impacted SnoreStop NasoSpray was sold in 0.3 fluid ounce bottles 9 ML with a single plastic bottle with a nasal pump as a delivery system. The product has a clear transparent plastic box labeled as SnoreStop NasoSpray.

It has a lot code of 2373 21222. The first part of the lot code 2373 is on a sticker on the bottom of the bottle, and the second part of the lot code 21222 is on a sticker on the outer packaging.

The recalled anti-snoring aid was sold nationwide in health food stores and online. Consumers are urged to stop using the SnoreStop NasoSpray and return it to the place of purchase.

Questions about the recall can be directed to Green Pharmaceuticals at 1 : 805 - 388 - 0600, Monday through Friday from 8 a.m. to 5 p.m. PST, or by email at mail snorestop.com.

The FDA has identified the contamination in SnoreStop NasoSpray. Green Pharmaceuticals has not received any reports of adverse reactions related to the recall to date.

Consumers who have problems with the product are encouraged to see their healthcare provider.